Strides Pharma adj. PAT at Rs52.3cr in Q1FY20

For the quarter, EBITDA stood at Rs123.9cr, a growth of 155% yoy vs. Rs48.6cr over the corresponding quarter of the previous year.

from India Infoline News Service https://ift.tt/2ykUU91